ASX/RHYOA (ASX/RHYOA)

Australian Securities Exchange: ASX/RHYOA · AUD

A$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	22.3M
Revenue (ttm)	1.7M
Net income (ttm)	-5.9M
EPS (ttm)	-A$0.02
Volume	8,162

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.7M
Net income (ttm): -5.9M
EPS (ttm): -A$0.02
Market cap: 22.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-276

P25 -108P50 -50.6P75 1.1

ROIC-129.5

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/RHYOA indicators

Market & fundamental data

Available fields

154

Groups with data

Currency

AUD

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-03
Enterprise value	AUD 19.1M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2017
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	AU0000440026
Last earnings date	2026-02-18
Last refreshed	2026-10-30
Market cap	AUD 22.3M
Next earnings date	2026-11-03
Price	AUD 0.01
Price currency	AUD
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-23
Symbol	asx/RHYOA
Website	https://rhythmbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-177.42%
EV/Sales	10.97x
FCF / EV yield	-27.53%
FCF yield	-23.59%
Industry forward P/E	17.45x
Industry P/E	63.53x
P/B ratio	6.13x
P/S ratio	12.81x
Price / tangible book value	7.89x
Sector forward P/E	34.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	76.29%
Operating margin	-336.37%
Pretax margin	-340.67%
ROA	-96.19%
ROA (5Y)	-90.73%
ROCE	-156.79%
ROE	-276%
ROE (5Y)	-259.75%
ROIC	-129.49%
SBC / revenue	24.52%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	-57.18%
Gross profit growth (Q)	61.11%
Gross profit growth 3Y	-24.58%
Gross profit growth 5Y	3.68%
Net income growth quarters	1
Net income growth years	0
Revenue growth	-47.67%
Revenue growth (Q)	-25.87%
Revenue growth (QoQ)	-92.69%
Revenue growth 3Y	-17.46%
Revenue growth 5Y	9.45%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -25,797
Depreciation and amortization	AUD 189,283
EBIT	AUD -5.9M
EBITDA	AUD -5.7M
EPS	AUD -0.02
Financing cash flow	AUD 7.2M
Free cash flow	AUD -5.3M
Free cash flow minus SBC	AUD -5.7M
Gross profit	AUD 1.3M
Investing cash flow	AUD -22,750
Net borrowing	AUD -1.3M
Net cash flow	AUD 2M
Net income	AUD -5.9M
Operating cash flow minus SBC	AUD -5.7M
Operating income	AUD -5.9M
Revenue	AUD 1.7M
Stock-based compensation	AUD 426,905

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.05
Book value per share	AUD 0.01
Debt / equity	0.07
Goodwill	AUD 531,021
Interest coverage	-78.28
Long-term assets	AUD 1M
Long-term liabilities	AUD 97,359
Net cash (debt)	AUD 3.2M
Net cash / market cap	14.32%
Net cash growth	751.42%
Net debt / equity	-0.88
Piotroski F-Score	2
Property, plant and equipment	AUD 206,201
Shareholders' equity	AUD 3.6M
Tangible book value	AUD 2.8M
Tangible book value per share	AUD 0.01
Total assets	AUD 4.8M
Total cash	AUD 3.4M
Total debt	AUD 247,980
Total liabilities	AUD 1.1M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.46
Current assets	AUD 3.8M
Current liabilities	AUD 1M
Current ratio	3.61
Inventory turnover	9.11
Net working capital	AUD -552,908
Quick ratio	3.36
Working capital	AUD 2.7M
Working capital turnover	1.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-24.14%
Shareholder yield	-24.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
1M price change	-61.54%
1M total return	-61.54%
20-day SMA	AUD 0.03
3M price change	-50%
3M total return	-50%
50-day SMA	AUD 0.06
52-week high	AUD 0.13
52-week high date	2026-02-10
52-week low	AUD 0.01
52-week low date	2025-12-09
6M price change	-86.67%
6M total return	-86.67%
All-time high	AUD 0.13
All-time high date	2026-02-09
All-time low	AUD 0.01
All-time low date	2025-12-09
Average true range (ATR)	AUD 0.01
Average volume	288.1K
Change from 52-week high	-92.31%
Change from 52-week low	25%
Change from all-time high	-92.31%
Change from all-time low	25%
Change from open	0%
Day's gap	0%
Dollar volume	AUD 81.62
High price	AUD 0.01
Low price	AUD 0.01
Monthly RSI	0
Open price	AUD 0.01
Previous close	AUD 0.01
Price vs 20-day SMA	-60.63%
Price vs 50-day SMA	-82.21%
Relative volume	0.03
RSI	30.24
Sharpe ratio	1.37
Sortino ratio	2.11
Volume	8.2K
Weekly RSI	46.28
YTD price change	-50%
YTD total return	-50%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	268.1M
Shares change (QoQ)	10.27%
Shares change (YoY)	24.14%
Shares held by insiders	9.32%
Shares held by institutions	7.01%

Deeper analysis on ASX/RHYOA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/RHYOA report

Is a complete ASX/RHYOA research report available?

No complete published report is available for asx/RHYOA (ASX/RHYOA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/RHYOA (ASX/RHYOA)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/RHYOA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/RHYOA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/RHYOA

Frequently asked questions